In a rare pair of papers published back-to-back in the journal Genes & Development, research teams led by senior author ...

An experimental drug has successfully disrupted the activity of MYC, a notoriously difficult-to-target cancer protein. The ...

In a rare pair of papers published back-to-back in the journal Genes & Development, research teams led by senior author Anindya Bagchi, PhD, associate professor in the Cancer Genome and Epigenetics ...

A first-in-class therapy to target MYC, one of the most sought-after and difficult targets in cancer biology, showed promise ...

A gene called Myc (pronounced 'mick') that is among the most important drivers of cancer in both mice and humans also plays a newly discovered crucial role in aging. A gene called Myc (pronounced ...

The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...

Researchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in a phase I clinical trial. Until now, no other drug has been able to do this safely and ...

Knowing the precise mechanisms by which MYC drives muscle growth could prove instrumental in creating therapies that reduce muscle loss from aging, potentially improving independence, mobility and ...

An oncology drug abandoned decades ago is getting a second look, with new research uncovering a mechanism that could offer an ...

A gene called Myc (pronounced "mick") that is among the most important drivers of cancer in both mice and humans also plays a newly discovered crucial role in aging, according to a new Cell Reports ...